Femtosecond laser-assisted implantation of complete versus incomplete rings for keratoconus treatment
Received 6 September 2014
Accepted for publication 1 November 2014
Published 20 January 2015 Volume 2015:9 Pages 121—127
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Scott Fraser
Mohamed Hosny, Esraa El–Mayah, Mohamed Karim Sidky, Mohamed Anis
Department of Ophthalmology, Cairo University, Giza, Egypt
Purpose: To compare complete versus incomplete ring implantation for keratoconus correction.
Methods: We investigated 25 eyes of keratoconic patients, of which 15 had femtosecond-assisted MyoRing corneal implantation (Group 1) and 10 had femtosecond-assisted Keraring segments (Group 2). Uncorrected distance visual acuity (UCVA), best corrected distance visual acuity (BCVA), mean K (Km), sphere, topographic cylinder, and corneal asphericity value (Q-value) were measured in all eyes preoperatively and at 4 weeks postoperatively (1 month).
Results: In Group 1, the Km change was -6.15±2.16 D, with a mean change in sphere of 4.45±2.18 D and a mean change in refractive cylinder of 2.32±3 D. UCVA change was -0.57±0.273 logarithm of the minimum angle of resolution (LogMAR), BCVA change was -0.2±0.27 (LogMAR), and the Q-value change was 0.43±2.6. In Group 2, the Km change was -3.15±1.68 D, UCVA change was -0.48±0.37 (LogMAR), BCVA change was -0.09±0.15 (LogMAR), and the Q-value change was 0.5±0.21. Changes in the means did not significantly differ between groups, except for the Km change, which was significantly greater in Group 1 than in Group 2 (P=0.05).
Conclusion: Both complete ring and ring segment implantation are effective for improving corneal and visual parameters in keratoconus. Complete ring implantation may have a greater flattening effect on the anterior corneal surface.
Keywords: KeraRing, MyoRing, keratoconus, femtosecond
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]